End Veterans Overdose Act of 2026
- Bill Number
- S. 3758
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 2
- Policy Area
- Armed Forces and National Security
- Status
- Introduced
- Latest Action
- 2026-03-18: Committee on Veterans' Affairs. Ordered to be reported with an amendment in the nature of a substitute favorably.
- Last Updated
- 2026-03-19T11:03:28Z
AI-Generated Summary
Purpose
The End Veterans Overdose Act of 2026 aims to reduce opioid overdose deaths among veterans by ensuring free and easy access to life-saving medications, such as naloxone (a drug that reverses opioid overdoses), for eligible veterans and their caregivers through the Department of Veterans Affairs (VA).
Key Provisions
- Availability of Medications: The VA Secretary must provide "covered medications" (opioid overdose rescue drugs like naloxone) at no cost and without needing a prescription to "covered veterans" (those eligible for VA health care under existing law) and their "caregivers" (family members or support providers enrolled in VA caregiver programs) at VA pharmacies.
- Educational Support: Anyone receiving the medication must also get information on how to use it properly.
- Privacy Protections: The VA can only collect personal information necessary for providing the medication, and it must be used solely to deliver, evaluate, and improve health care. This information cannot be used to block employment, prove past drug use, or label someone as an unlawful drug user or addict.
- Reporting Requirements: Within two years of implementation, and every year after, the VA must report to Congress on:
- The number of veterans and caregivers who received the medications.
- Feasibility of expanding access to immediate family members of veterans.
- Feasibility of including non-VA health providers (those contracted by the VA for veteran care).
- Trends in how often the medications are used.
- Any other VA recommendations for improving the program.
Significant Changes to Existing Law
This bill introduces a new federal requirement for the VA to distribute opioid overdose rescue medications without prescriptions, which is not currently mandated under Title 38 of the U.S. Code (the main law governing veterans' benefits). It adds strict limits on how personal health data can be used in this context, building on but expanding existing VA privacy rules to prevent misuse related to drug history or employment. It also creates ongoing congressional oversight through annual reports, which did not previously exist for this specific service.
Potential Impacts
- On Government Agencies: The VA will need to update pharmacy operations, train staff, and track usage for reports, potentially increasing administrative costs but improving emergency response capabilities within the agency.
- On Citizens: Eligible veterans and caregivers gain immediate, barrier-free access to potentially life-saving drugs, which could lower overdose rates and save lives, especially for those at risk from prescription opioids or substance use disorders common among veterans.
- On International Relations: No direct impacts, as the bill focuses solely on domestic VA services for U.S. veterans.
Main Stakeholders Affected
- Veterans: Primarily "covered veterans" eligible for VA health care, who may benefit from easier access to overdose reversal tools.
- Caregivers: Family or support caregivers enrolled in VA programs, empowered to respond to emergencies.
- Department of Veterans Affairs: Responsible for implementation, distribution, privacy compliance, and reporting.
- Congress: Receives oversight reports to evaluate and potentially expand the program.
- Health Care Providers: Non-VA providers under VA contracts could be affected if expansion recommendations are adopted.
Notable Legal, Constitutional, or Political Implications
- Legal: Strengthens patient privacy under health laws like HIPAA (Health Insurance Portability and Accountability Act, which protects medical information) by explicitly prohibiting certain uses of data, reducing risks of discrimination based on health history.
- Constitutional: Aligns with due process protections by limiting government use of personal information, avoiding potential Fourth Amendment (search and seizure) concerns over unwarranted data collection.
- Political: Bipartisan support (introduced by Senators Shaheen and Crapo from different parties) highlights a non-partisan focus on veteran health and the opioid crisis; the reporting mechanism ensures accountability and could lead to future expansions without new legislation.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (1)
Recent Actions
- 2026-03-18: Committee on Veterans' Affairs. Ordered to be reported with an amendment in the nature of a substitute favorably.
- 2026-02-02: Read twice and referred to the Committee on Veterans' Affairs.
- 2026-02-02: Introduced in Senate
Bill Versions
- End Veterans Overdose Act of 2026 — issued 2026-02-02 — PDF (5 pages)